Capricor Therapeutics, Inc.
DE ˙ DB ˙ US14070B3096
€22.99 ↓ -0.18 (-0.78%)
2026-06-04
주가
SecurityDE:4LN2 / Capricor Therapeutics, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership119,372 shares
Latest Disclosed Value $ 3,445,076
Barclays Plc ownership in 4LN2 / Capricor Therapeutics, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 119,372 shares of Capricor Therapeutics, Inc. (DE:4LN2) valued at $2,972,363 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 55,093 shares of Capricor Therapeutics, Inc.. This represents a change in shares of 116.67% during the quarter. The current value of the position is $2,744,362 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (4LN2) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:4LN2 / Capricor Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F CAPRICOR THERAPEUTICS COM 14070B309 119,372 64,279 116.67 3,445 767.76 0.0008
2026-03-31 2025-09-30 13F/A-3 CAPRICOR THERAPEUTICS COM 14070B309 55,093 -75,818 -57.92 397 -69.44 0.0001
2026-03-19 2025-09-30 13F/A-2 CAPRICOR THERAPEUTICS COM 14070B309 36,296 -94,615 552 0.0001
2025-11-12 2025-09-30 13F CAPRICOR THERAPEUTICS COM 14070B309 55,093 -75,818 397 0.0001
2026-02-27 2025-06-30 13F/A-2 CAPRICOR THERAPEUTICS COM 14070B309 130,911 53,362 68.81 1,300 76.73 0.0003
2025-08-14 2025-06-30 13F/A-1 CAPRICOR THERAPEUTICS COM 14070B309 130,911 53,362 1 0.0003
2025-08-13 2025-06-30 13F CAPRICOR THERAPEUTICS COM 14070B309 130,911 53,362 1 0.0001
2026-03-17 2025-03-31 13F/A-1 CAPRICOR THERAPEUTICS COM 14070B309 77,549 -12,101 -13.50 736 -40.58 0.0002
2025-05-15 2025-03-31 13F CAPRICOR THERAPEUTICS COM 14070B309 77,549 -12,101 1 0.0002
2026-03-19 2024-12-31 13F/A-1 CAPRICOR THERAPEUTICS COM 14070B309 89,650 53,354 147.00 1,237 124.09 0.0003
2025-02-13 2024-12-31 13F CAPRICOR THERAPEUTICS COM 14070B309 89,650 53,354 1 0.0003
2026-03-31 2024-09-30 13F/A-2 CAPRICOR THERAPEUTICS COM 14070B309 36,296 18,724 106.56 552 565.06 0.0001
2024-11-19 2024-09-30 13F/A-1 CAPRICOR THERAPEUTICS COM 14070B309 36,296 18,724 1 0.0001
2024-11-15 2024-09-30 13F CAPRICOR THERAPEUTICS COM 14070B309 36,296 18,724 1 0.0001
2026-03-23 2024-06-30 13F/A-1 CAPRICOR THERAPEUTICS COM 14070B309 17,572 17,572 84 0.0000
2024-08-14 2024-06-30 13F CAPRICOR THERAPEUTICS COM 14070B309 17,572 17,572 0 0.0000
2022-02-23 2021-12-31 13F/A-1 CAPRICOR THERAPEUTICS COM 14070B309 0 -6,330 -100.00 0 -100.00
2022-02-14 2021-12-31 13F CAPRICOR THERAPEUTICS COM 14070B309 0 -6,330 0
2021-11-09 2021-09-30 13F CAPRICOR THERAPEUTICS COM 14070B309 6,330 4,501 246.09 25 177.78 0.0000
2021-08-13 2021-06-30 13F CAPRICOR THERAPEUTICS COM 14070B309 1,829 1,731 1,766.33 9 0.0000
2021-05-13 2021-03-31 13F CAPRICOR THERAPEUTICS COM 14070B309 98 98 0 0.0000
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F CAPRICOR THERAPEUTICS OPT Put 328,900 291.08 9,492 1,466.34 n/a n/a n/a
2026-03-31 2025-09-30 13F/A CAPRICOR THERAPEUTICS OPT Put 84,100 -10.63 606 -35.12 n/a n/a n/a
2025-11-12 2025-09-30 13F CAPRICOR THERAPEUTICS OPT Put 84,100 606 n/a n/a n/a
2025-08-14 2025-06-30 13F/A CAPRICOR THERAPEUTICS OPT Put 94,100 1 n/a n/a n/a
2026-02-27 2025-06-30 13F/A CAPRICOR THERAPEUTICS OPT Put 94,100 934 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.